Effect of Extracorporeal Shock Wave Therapy of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2/PHASE3

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-11-30

Study Completion Date

2013-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Plantar fasciitis is one of the most common causes of heel pain. This study will be performed in the purpose of determination the effects of extracorporeal shock wave therapy of gastrosoleus trigger points in patients with plantar fasciitis

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Extracorporeal Shockwave Therapy on Gait Parameters in Patients With Planter Fascitis

NCT06310122

Plantar Fascitis Extracorporeal Shockwave Therapy

NOT_YET_RECRUITING NA

Myofascial Points Treatment With Focused Extracorporeal Shock Waves (ESW)

NCT05090059

Plantar Fasciitis Myofascial Trigger Point Pain Foot Injury

COMPLETED NA

Comparing Two Protocols of Shock Wave Therapy for Patients With Plantar Fasciitis

NCT06174142

Plantar Fasciitis

NOT_YET_RECRUITING NA

Factors Affecting Response to Extracorporeal Shock Wave Therapy in Plantar Fasciitis: A Cross-sectional Clinical Study

NCT07006389

Plantar Fasciitis Plantar Heel Pain

ENROLLING_BY_INVITATION

Shock Wave Therapy for Sural Myofascial Pain Associated to Chronic Heel Pain

NCT04385329

Tendinopathy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Plantar fasciitis is the most common cause of inferior heel pain, A great variety of therapies have been reported for the treatment of plantar fasciitis including extracorporeal shock wave therapy. Gastrosoleus muscle dysfunction is one of the most common contributing factors to this disease .Despite the long history and the fact that this is a common diagnosis made in clinical practice, the exact cause and best treatment for this condition still are being explored. Although there is lack of high-quality studies demonstrating the efficacy of extracorporeal shock wave therapy of gastrosoleus trigger points in patients with plantar fasciitis , this study will be performed to examine the effect of extracorporeal shock wave therapy of gastrosoleus trigger points in patients with plantar fasciitis

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Plantar Fasciitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Extracorporeal shock wave therapy 1

Extracorporeal shock wave therapy , (3000 shock waves/session of 0.2 mJ/mm2) for heel region and (400 shock waves/session of 0.2 mJ/mm2 per each trigger point) for gastrosoleus trigger points , 3 sessions at weekly intervals

Group Type ACTIVE_COMPARATOR

Extracorporeal shock wave therapy 1

Intervention Type PROCEDURE

Extracorporeal shock wave therapy , (3000 shock waves/session of 0.2 mJ/mm2) for heel region and (400 shock waves/session of 0.2 mJ/mm2 per each trigger point) for gastrosoleus trigger points , 3 sessions at weekly intervals

Extracorporeal shock wave therapy 2

Extracorporeal shock wave therapy , (3000 shock waves/session of 0.2 mJ/mm2) for heel region , 3 sessions at weekly intervals

Group Type PLACEBO_COMPARATOR

Extracorporeal shock wave therapy 2

Intervention Type PROCEDURE

Extracorporeal shock wave therapy , (3000 shock waves/session of 0.2 mJ/mm2) for heel region , 3 sessions at weekly intervals

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Extracorporeal shock wave therapy 1

Extracorporeal shock wave therapy , (3000 shock waves/session of 0.2 mJ/mm2) for heel region and (400 shock waves/session of 0.2 mJ/mm2 per each trigger point) for gastrosoleus trigger points , 3 sessions at weekly intervals

Intervention Type PROCEDURE

Extracorporeal shock wave therapy 2

Extracorporeal shock wave therapy , (3000 shock waves/session of 0.2 mJ/mm2) for heel region , 3 sessions at weekly intervals

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. clinical diagnosis of plantar fasciitis
2. having at least one Gastrosoleus trigger point concomitantly.
3. having no response to conservative treatments for at least 3 months
4. willingness to participate

Exclusion Criteria

1. Dysfunction of the knee or ankle
2. Neurologic abnormalities
3. Bleeding tendency (hereditary or acquired)
4. Nerve entrapment syndrome
5. A previous operation on the heel
6. Pregnancy
7. Evidences of Infection in lower limbs
8. A medical History of tumor
9. previous local corticosteroid injection within 12 weeks

Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No